Search research articles
Contact Us
Filters
Showing results (1-10 of 27) with videos related to
Page
of 3
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
September 1, 2022
[Indications and Practice of a New Radionuclide Therapy, 177Lu-DOTATATE in Japan]
Shoko Takano, Noritoshi Kobayashi, Yasushi Ichikawa, et al.
Cancer Science
|
March 10, 2022
Neuroendocrine tumor theranostics
Yasushi Ichikawa, Noritoshi Kobayashi, Shoko Takano, et al.
Anticancer Research
|
May 29, 2023
Long-term Outcomes of Early-stage Non-stomach Gastrointestinal Mucosa-associated Lymphoid Tissue Lymphoma Treated With Radiation Therapy
Eiko Ito, Ichiro Ogino, Madoka Sugiura, et al.
Kaku Igaku. the Japanese Journal of Nuclear Medicine
|
September 18, 2025
[A Report on Health Resource Use in Internal Radiation Therapy Using Lutetium-177 (<sup>177</sup>Lu)-PSMA-617]
Shoko Takano, Tatsuya Higashi, Katsuhiko Kato, et al.
Annals of Nuclear Medicine
|
September 18, 2014
Definitive chemo-radiotherapy for squamous cell carcinoma of the pharynx: impact of baseline low hemoglobin level (<12 g/dL) and post-radiation therapy F-18 FDG-PET/CT
Ryoko Katahira-Suzuki, Masaharu Hata, Ukihide Tateishi, et al.
JMIR Research Protocols
|
February 19, 2026
Evaluation of Reduced Single-Photon Emission Computed Tomography Imaging Protocols and Software Variability in <sup>177</sup>Lu-DOTATATE Dosimetry: Protocol for an Exploratory Observational Trial
Takayuki Yagihashi, Kenta Miwa, Noriaki Miyaji, et al.
Oral Diseases
|
July 13, 2025
Infectious Complications in Patients Receiving Superselective Intra-Arterial Chemoradiotherapy for Oral Squamous Cell Carcinoma
Hideaki Kato, Takashi Ohya, Toshiyuki Koizumi, et al.
Journal of Hepato-Biliary-Pancreatic Sciences
|
June 26, 2021
Retrospective study of peptide receptor radionuclide therapy for Japanese patients with advanced neuroendocrine tumors
Noritoshi Kobayashi, Damian Wild, Felix Kaul, et al.
Cancers
|
July 27, 2022
Factors Contributing to Tumor Shrinkage after Peptide Receptor Radionuclide Therapy in Patients with Unresectable Neuroendocrine Tumors
Sho Hasegawa, Noritoshi Kobayashi, Damian Wild, et al.
In Vivo (Athens, Greece)
|
December 29, 2019
Outcome of Radiation Therapy for Locally Advanced Vulvar Carcinoma: Analysis of Inguinal Lymph Node
Yuki Mukai, Izumi Koike, Tatsuya Matsunaga, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 27) with videos related to
Sort By:
Page
of 3
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
September 1, 2022
[Indications and Practice of a New Radionuclide Therapy, 177Lu-DOTATATE in Japan]
Shoko Takano, Noritoshi Kobayashi, Yasushi Ichikawa, et al.
Cancer Science
|
March 10, 2022
Neuroendocrine tumor theranostics
Yasushi Ichikawa, Noritoshi Kobayashi, Shoko Takano, et al.
Anticancer Research
|
May 29, 2023
Long-term Outcomes of Early-stage Non-stomach Gastrointestinal Mucosa-associated Lymphoid Tissue Lymphoma Treated With Radiation Therapy
Eiko Ito, Ichiro Ogino, Madoka Sugiura, et al.
Kaku Igaku. the Japanese Journal of Nuclear Medicine
|
September 18, 2025
[A Report on Health Resource Use in Internal Radiation Therapy Using Lutetium-177 (<sup>177</sup>Lu)-PSMA-617]
Shoko Takano, Tatsuya Higashi, Katsuhiko Kato, et al.
Annals of Nuclear Medicine
|
September 18, 2014
Definitive chemo-radiotherapy for squamous cell carcinoma of the pharynx: impact of baseline low hemoglobin level (<12 g/dL) and post-radiation therapy F-18 FDG-PET/CT
Ryoko Katahira-Suzuki, Masaharu Hata, Ukihide Tateishi, et al.
JMIR Research Protocols
|
February 19, 2026
Evaluation of Reduced Single-Photon Emission Computed Tomography Imaging Protocols and Software Variability in <sup>177</sup>Lu-DOTATATE Dosimetry: Protocol for an Exploratory Observational Trial
Takayuki Yagihashi, Kenta Miwa, Noriaki Miyaji, et al.
Oral Diseases
|
July 13, 2025
Infectious Complications in Patients Receiving Superselective Intra-Arterial Chemoradiotherapy for Oral Squamous Cell Carcinoma
Hideaki Kato, Takashi Ohya, Toshiyuki Koizumi, et al.
Journal of Hepato-Biliary-Pancreatic Sciences
|
June 26, 2021
Retrospective study of peptide receptor radionuclide therapy for Japanese patients with advanced neuroendocrine tumors
Noritoshi Kobayashi, Damian Wild, Felix Kaul, et al.
Cancers
|
July 27, 2022
Factors Contributing to Tumor Shrinkage after Peptide Receptor Radionuclide Therapy in Patients with Unresectable Neuroendocrine Tumors
Sho Hasegawa, Noritoshi Kobayashi, Damian Wild, et al.
In Vivo (Athens, Greece)
|
December 29, 2019
Outcome of Radiation Therapy for Locally Advanced Vulvar Carcinoma: Analysis of Inguinal Lymph Node
Yuki Mukai, Izumi Koike, Tatsuya Matsunaga, et al.
Page
of 3